Oleylamine, 80-90%

CAT:
804-HY-W011696-01
Size:
100 g
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Oleylamine, 80-90% - image 1

Oleylamine, 80-90%

  • Description:

    Oleylamine, 80-90% (cis-1-Amino-9-octadecene, 80-90%) is a multifunctional reagent for metal ion coordination and nanoparticle surface modification. Oleylamine, 80-90% is a solvent, surfactant and reducing agent in the synthesis of metal oxide nanoparticles. Oleylamine, 80-90% can regulate nanoparticle morphology, magnetization and water proton relaxation rate through thiol-ene "click" reaction, and increase the colloidal stability of nanoparticles in organic reagents. Oleylamine, 80-90% is mainly used in the research and application of nanomaterial synthesis, biomedical imaging (MRI contrast agents, fluorescent probes), cancer cell targeting and drug delivery[1][2].
  • Product Name Alternative:

    Cis-1-Amino-9-octadecene, 80-90%
  • UNSPSC:

    12352200
  • Hazard Statement:

    H302, H304, H314, H335, H373, H410
  • Target:

    Biochemical Assay Reagents
  • Type:

    Biochemical Assay Reagents
  • Related Pathways:

    Others
  • Field of Research:

    Others
  • Assay Protocol:

    https://www.medchemexpress.com/oleylamine-80-90.html
  • Purity:

    97.0
  • Solubility:

    DMSO : 14.29 mg/mL (ultrasonic; warming; heat to 60°C)
  • Smiles:

    CCCCCCCC/C=C\CCCCCCCCN
  • Molecular Formula:

    C18H37N
  • Molecular Weight:

    267.49
  • Precautions:

    H302, H304, H314, H335, H373, H410
  • References & Citations:

    [1]Georgiadou V, et al. Oleylamine as a beneficial agent for the synthesis of CoFeâ‚‚Oâ‚„ nanoparticles with potential biomedical uses. Dalton Trans. 2014 May 7;43 (17) :6377-88.|[2]Mourdikoudis S, et al., Oleylamine in nanoparticle synthesis. Chemistry of Materials, 2013, 25 (9) : 1465-1476.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, protect from light)
  • Scientific Category:

    Biochemical Assay Reagents
  • Clinical Information:

    No Development Reported
  • CAS Number:

    [112-90-3]